| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/08/2004 | US20040006395 Vascularization enhanced graft constructs |
| 01/08/2004 | US20040006219 Comprises membrane protein for diagnosis, prevention and treatment of cell proliferative and inflammatory disorders |
| 01/08/2004 | US20040006217 Comprises coagulation factor VIIa/VII receptor for treatment and prevention of thrombosis, septic shock and adult respiratory distress syndrome (ARDS); anticoagulants; thrombolytic agents |
| 01/08/2004 | US20040006216 Comprises immunoglobulin for treating cancer; immunosuppressant; immunotherapy |
| 01/08/2004 | US20040006215 Human monoclonal antibodies against CD30 |
| 01/08/2004 | US20040006211 Comprises membrane protein for diagnosis, prevention and treatment of cell proliferative and inflammatory disorders |
| 01/08/2004 | US20040006207 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 01/08/2004 | US20040006206 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/08/2004 | US20040006205 Comprises g-protein coupled receptor polypeptides for diagnosis, prevention and treatment of cancers, infections and dyslipidemias |
| 01/08/2004 | US20040006131 Compounds selectively inhibiting gamma 9 delta 2 T lymphocytes |
| 01/08/2004 | US20040006031 For therapy of disease or condition such as cholesterol metabolism, cardiovascular disease, atherosclerosis, angiogenesis |
| 01/08/2004 | US20040006028 Administering a therapeutically effective amount of a flavin N-oxide; exposing flavin N-oxide to an activator, such that activation of the flavin N- oxide results in damage to the DNA in cancer cells without damage to the DNA in normal cells |
| 01/08/2004 | US20040006026 For use as antibiotics, in therapy of infectious diseases |
| 01/08/2004 | US20040006018 Isolated CT-1, isolated DNA encoding CT-1, and recombinant or synthetic methods of preparing CT-1 are disclosed. CT-1 is shown to bind to and activate the receptor, LIFR beta . These CT-1 molecules are shown to influence hypertrophic activity, |
| 01/08/2004 | US20040006003 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 01/08/2004 | US20040005712 Transforming B lymphocytes with Epstein-Barr virus, incubating transformed B lymphocytes with flavin N-oxide photosensitizer, adding non-toxic antioxidant, and exposing lymphocytes to activator such as photoradiation to activate photosensitizer |
| 01/08/2004 | US20040005711 Alphaviral vector system comprising papilloma viral orgin of replication and antitumor agent for prevention and treatment urogenital cancer; gene therapy |
| 01/08/2004 | US20040005706 Antisense modulation of DEXRAS1 expression |
| 01/08/2004 | US20040005705 Comprises oligonucleotides for controlling expression of phospholipase D2 and treating cancer and nervous system disorders; gene expression inhibition; antisense therapy |
| 01/08/2004 | US20040005704 Propagating neuronal cells in reduced oxygen environment for treating parkinson's and neurodegenerative diseases; in vitro culture and cell differentiation/proliferation; gene therapy; tissue engineering; antiapoptosis |
| 01/08/2004 | US20040005703 Chemical cleaning of biological material |
| 01/08/2004 | US20040005702 Immortalized human pancreatic cell line produced by electrofusion and which secretes insulin for treating diabetes; gene therapy; tissue engineering |
| 01/08/2004 | US20040005701 Using trophoblast inducing factor to differentiate primate stem cells into trophoblast; tissue engineering; cell differentiation/proliferation |
| 01/08/2004 | US20040005699 Apparatus comprised of mutiple compartments and gas permeable membranes for supporting and feeding living tissue |
| 01/08/2004 | US20040005683 Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 01/08/2004 | US20040005666 Methods and reagents for modulating cholesterol levels |
| 01/08/2004 | US20040005665 Comprises nucleotide sequences coding membrane proteins for diagnosing, preventing and treating inflammatory, tumorous and nervous system disorders |
| 01/08/2004 | US20040005661 Comprises mitogenic factor for propagation neuronal cells and treating nervous system disorders |
| 01/08/2004 | US20040005660 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 01/08/2004 | US20040005643 Anti-human tenascin monoclonal antibody |
| 01/08/2004 | US20040005630 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 01/08/2004 | US20040005626 Comprises nucleotide sequences coding membrane protein for diagnosing and treating inflammatory and tumor disorders |
| 01/08/2004 | US20040005604 Comprises nucleotide sequences coding enzymatic polypeptide for degumming oil and food processing; antisense therapy |
| 01/08/2004 | US20040005598 Comprises nucleotide sequences coding protein upregulated in metastatic prostate cancer (PUMPCn) for diagnosis and treatment of tumors; antiproliferative agents; anticarcinogenic agents |
| 01/08/2004 | US20040005589 Isomaltulose synthases, polynucleotides encoding them and uses therefor |
| 01/08/2004 | US20040005581 Comprises nucleotide sequences coding vanilloid receptor-like receptor (VR4) for diagnosing and treating pain, inflammation, neurodegeneration, cardiovascular, cancer and urogenital diseases; drug screening |
| 01/08/2004 | US20040005579 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005577 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005576 Comprises polypeptides for diagnosing, prognosing and preventing cancer, nervous system, developmental and metabolic disorders |
| 01/08/2004 | US20040005575 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005563 Detecting transcription products associated urogenital cancers drug screening; drug screening; antiproliferative agents |
| 01/08/2004 | US20040005561 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 01/08/2004 | US20040005553 Comprises membrane protein for treating cancer, inflammation and autoimmune disorders |
| 01/08/2004 | US20040005549 Comprises expression vector capable of efficient replication for use as diagnostic tool in viral gene transfer, propagation, drug screening and vaccine development |
| 01/08/2004 | US20040005363 A biodegradable biopolymer material consists of silk fibroin from domesticated silkworm; silk fibroin from wild silkworm; a composite material comprising silk fibroin from domesticated silkworm and silk fibroin from wild silkworm; or a composite |
| 01/08/2004 | US20040005334 Redirection of cellular immunity by receptor chimeras |
| 01/08/2004 | US20040005328 Novel antigens of B. catarrhalis are provided, together with their use in vaccines as well as methods of diagnosing and/or detection. Branhamella catarrhalis (also known as Moraxella catarrhalis) is a gram-negative aerobic bacterium that causes |
| 01/08/2004 | US20040005325 Helicobacter felis vaccine |
| 01/08/2004 | US20040005323 Efficient method for generating human antibodies in particular which are specific to be RSV fusion protein which combines in vitro primary of human spleen cells and antigen boosting in SCID mice is taught. This method provides for very high human |
| 01/08/2004 | US20040005322 Compositions and methods related to TIM-3, a Th1-specific cell surface molecule |
| 01/08/2004 | US20040005316 Use of HMG fragments as anti-inflammatory agents |
| 01/08/2004 | US20040005315 Administering an immunosuppressive agent that depletes T cells and anti-alpha beta T cell receptor antibodies, and implanting an allograft into the recipient. |
| 01/08/2004 | US20040005303 In vivo induction for enhanced function of isolated hepatocytes |
| 01/08/2004 | US20040005301 Identification and high-yield isolation of human pancreatic islet progenitor and stem cells |
| 01/08/2004 | US20040005300 By transplanting with hematopoietic stem cells from a donor that are matched at the major histocompatibility complex class I K locus with the recipient hematopoietic microenvironment. |
| 01/08/2004 | US20040005299 Method for producing pseudo islets |
| 01/08/2004 | US20040005298 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 01/08/2004 | US20040005297 Five layers of biocompatible material, each of which is coated with a biological sealant; disposed within a bioreactor having means for mechanically stimulating each of the cells in each of said layers at distinct vibration frequencies. |
| 01/08/2004 | US20040005295 Forming a conduction block at the cardiac location associated with the arrhythmia by delivering fibroblast cells to the location. |
| 01/08/2004 | US20040005292 Antisense modulation of SMRT expression |
| 01/08/2004 | US20040005291 Modulating antigen specific immune responses, treating autoimmune diseases, such as multiple sclerosis, and cancer, and for modulating cell growth. |
| 01/08/2004 | CA2491861A1 Human igm antibody lysing activated lymphocytes under mediation by homologous complement |
| 01/08/2004 | CA2491698A1 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis |
| 01/08/2004 | CA2491567A1 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
| 01/08/2004 | CA2491528A1 Decellularized tissue |
| 01/08/2004 | CA2491480A1 Humanized anti-lymphotoxin beta receptor antibodies |
| 01/08/2004 | CA2491363A1 Antibodies and uses thereof |
| 01/08/2004 | CA2491212A1 Protein production methods and modified cells for use therein |
| 01/08/2004 | CA2491043A1 Method for preparing animal or human adult stem cells and therapeutic use thereof |
| 01/08/2004 | CA2490411A1 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490401A1 Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
| 01/08/2004 | CA2490348A1 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 01/08/2004 | CA2490283A1 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 01/08/2004 | CA2490261A1 Differentiation modulating agents and uses therefor |
| 01/08/2004 | CA2490017A1 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 01/08/2004 | CA2489376A1 Methods of organ regeneration |
| 01/08/2004 | CA2486543A1 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/07/2004 | EP1378574A1 Enhanced production of taxol and taxanes by cell cultures of taxus species |
| 01/07/2004 | EP1378572A1 Bmp-11 compositions |
| 01/07/2004 | EP1378570A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 01/07/2004 | EP1378566A2 Modified reductase from Penicillium citrinum and its encoding gene |
| 01/07/2004 | EP1378525A2 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods |
| 01/07/2004 | EP1378524A2 Recombinant thrombin receptor antibodies and their use |
| 01/07/2004 | EP1378522A2 Methods of enhancing bioactivity of chemokines |
| 01/07/2004 | EP1378520A1 Cyclic single strand trispecific antibody |
| 01/07/2004 | EP1378257A2 Collagen-based graft prosthesis |
| 01/07/2004 | EP1377901A2 Method for the evolutionary design of biochemical reaction networks |
| 01/07/2004 | EP1377833A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections |
| 01/07/2004 | EP1377826A2 Opiate receptors |
| 01/07/2004 | EP1377680A2 Diagnosis and treatment of cancer: i |
| 01/07/2004 | EP1377672A2 Vector constructs |
| 01/07/2004 | EP1377670A1 Transgenic plants with reduced adenylate kinase activity showing an increased accumulation of starch |
| 01/07/2004 | EP1377663A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 01/07/2004 | EP1377661A2 Compositions and methods for the treatment and repair of defects or lesions in articular cartilage using synovial-derived tissue or cells |
| 01/07/2004 | EP1377611A2 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 01/07/2004 | EP1377609A2 Mhc molecule constructs and their uses for diagnosis and therapy |
| 01/07/2004 | EP1377608A1 Insulin precursors and a process for their preparation |
| 01/07/2004 | EP1377607A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid |
| 01/07/2004 | EP1377604A2 Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides |
| 01/07/2004 | EP1377603A1 Protein cluster v |